Author: Mary-Louise Hoffman|| Date Published: June 30, 2022
The U.S. government is procuring up to 405 million COVID-19 vaccine doses from a partnership between Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) under a $3.2 billion firm-fixed-price contract.
The Department of Health and Human Services said Wednesday it expects to receive the initial doses for both adult and pediatric use in the fall.
“Vaccines have been a game-changer in our fight against COVID-19, allowing people to return to normal activities knowing that vaccines protect from severe illness,” said Xavier Becerra, secretary of HHS and a previous Wash100 Award winner.
The Biden administration plans to use a portion of reallocated funds from pandemic response efforts to pay for orders from Pfizer.
HHS collaborated with the Department of Defense on the procurement.
A Food and Drug Administration advisory panel recommended the use of a component targeting the SARS-CoV-2 Omicron variant in the national booster vaccination initiative.
The Department of State has awarded spots on a multiple-award indefinite-delivery/indefinite-quantity contract with a combined potential value of $10 billion…
The Federal Aviation Administration has awarded a potential five-year, $437.4 million contract to ASRC Federal Advanced Research to provide second-level…
Naval Supply Systems Command has awarded 24 companies positions on the $55 billion follow-on Worldwide Expeditionary Multiple Award Contract Territorial…
Lockheed Martin has received a $249 million indefinite-delivery/indefinite-quantity contract from the U.S. Navy to support the Surface Electronic Warfare Improvement Program,…
